TIGIT and breast cancer: In another study, peripheral blood from BC and colorectal cancer patients, observed LAG3 downregulation in patients with TIM3, TIGIT and PD-L1 upregulation [76], confirming the heterogeneous expression of these molecules also in circulating immune cells, and contributing to the complexity of this scenario.